{"protocolSection":{"identificationModule":{"nctId":"NCT03347786","orgStudyIdInfo":{"id":"GNI_verap"},"organization":{"fullName":"Global Neurosciences Institute","class":"OTHER"},"briefTitle":"Verapamil for Neuroprotection in Stroke","officialTitle":"Intraarterial Verapamil for Neuroprotection in Ischemic Stroke"},"statusModule":{"statusVerifiedDate":"2022-08","overallStatus":"RECRUITING","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2017-04-20","type":"ACTUAL"},"primaryCompletionDateStruct":{"date":"2023-04","type":"ESTIMATED"},"completionDateStruct":{"date":"2023-04","type":"ESTIMATED"},"studyFirstSubmitDate":"2017-11-09","studyFirstSubmitQcDate":"2017-11-15","studyFirstPostDateStruct":{"date":"2017-11-20","type":"ACTUAL"},"lastUpdateSubmitDate":"2022-08-08","lastUpdatePostDateStruct":{"date":"2022-08-10","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"PRINCIPAL_INVESTIGATOR","investigatorFullName":"Erol Veznedaroglu","investigatorTitle":"Director, Global Neurosciences Institute","investigatorAffiliation":"Global Neurosciences Institute"},"leadSponsor":{"name":"Global Neurosciences Institute","class":"OTHER"}},"oversightModule":{"oversightHasDmc":true,"isFdaRegulatedDrug":true,"isFdaRegulatedDevice":false},"descriptionModule":{"briefSummary":"The purpose of this research study is to test an experimental procedure called intra-arterial delivery of verapamil in patients diagnosed with acute ischemic stroke. This study investigates the safety of intra-arterial delivery of verapamil, a drug used to treat vasospasm (spasm of a blood vessel), and how it affects recovery from stroke. Recruitment is limited to patients that have received mechanical thrombectomy as standard of care."},"conditionsModule":{"conditions":["Ischemic Stroke"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["PHASE1"],"designInfo":{"allocation":"NA","interventionModel":"SINGLE_GROUP","primaryPurpose":"TREATMENT","maskingInfo":{"masking":"NONE"}},"enrollmentInfo":{"count":20,"type":"ESTIMATED"}},"armsInterventionsModule":{"interventions":[{"type":"DRUG","name":"Verapamil","description":"Intra-arterial delivery of verapamil following mechanical thrombectomy procedure"}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Serious Adverse Event","description":"Death","timeFrame":"3 months"},{"measure":"Serious Adverse Event","description":"Hemorrhagic conversion","timeFrame":"3 months"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Written informed consent\n* 18 years of age and over\n* Acute onset focal neurologic deficit consistent with acute ischemic stroke, or computed tomographic scan consistent with acute cerebral ischemia\n* Candidate for mechanical thrombectomy procedure\n* Onset of symptoms less than 8 hours\n* Measurable neurologic deficit (NIHSS \\>1)\n* Willingness to follow up with rehabilitation therapy\n* Anticipated life expectancy of at least 3 months\n\nExclusion Criteria:\n\n* Pregnancy or suspected pregnancy (pregnancy test will be done on women of child-bearing potential)\n* Hepatic and/or renal insufficiency (LFT's\\>3Ã— upper limit of normal; CrCl \\< 30ml/min)\n* Thrombocytopenia (platelet count \\<75,000/mm3)\n* History of intolerance to verapamil\n* Previous functional disability (modified Rankin \\> 1)\n* Stuporous or comatose\n* Unlikely to be available for 90 day follow-up\n* Severe stroke (NIHSS\\>22)","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"80 Years","stdAges":["ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"locations":[{"facility":"Crozer Keystone Health System","status":"RECRUITING","city":"Upland","state":"Pennsylvania","zip":"19013","country":"United States","contacts":[{"name":"Mandy Binning","role":"CONTACT","email":"MBinning@gnineuro.org"},{"role":"CONTACT","phone":"844-464-6387"}],"geoPoint":{"lat":39.85261,"lon":-75.38269}}]},"ipdSharingStatementModule":{"ipdSharing":"NO","description":"IPD will not be shared as this is a pilot study to determine safety"}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000020521","term":"Stroke"},{"id":"D000083242","term":"Ischemic Stroke"}],"ancestors":[{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"}],"browseLeaves":[{"id":"M21996","name":"Stroke","asFound":"Stroke","relevance":"HIGH"},{"id":"M10233","name":"Ischemia","relevance":"LOW"},{"id":"M2401","name":"Ischemic Stroke","asFound":"Ischemic Stroke","relevance":"HIGH"},{"id":"M5500","name":"Cerebrovascular Disorders","relevance":"LOW"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC23","name":"Symptoms and General Pathology"}]},"interventionBrowseModule":{"meshes":[{"id":"D000014700","term":"Verapamil"}],"ancestors":[{"id":"D000000889","term":"Anti-Arrhythmia Agents"},{"id":"D000002121","term":"Calcium Channel Blockers"},{"id":"D000049990","term":"Membrane Transport Modulators"},{"id":"D000045504","term":"Molecular Mechanisms of Pharmacological Action"},{"id":"D000077264","term":"Calcium-Regulating Hormones and Agents"},{"id":"D000045505","term":"Physiological Effects of Drugs"},{"id":"D000014665","term":"Vasodilator Agents"}],"browseLeaves":[{"id":"M17136","name":"Verapamil","asFound":"Reflex","relevance":"HIGH"},{"id":"M3903","name":"Anti-Arrhythmia Agents","relevance":"LOW"},{"id":"M5071","name":"Calcium","relevance":"LOW"},{"id":"M5088","name":"Calcium, Dietary","relevance":"LOW"},{"id":"M5074","name":"Calcium Channel Blockers","relevance":"LOW"},{"id":"M9479","name":"Hormones","relevance":"LOW"},{"id":"M17102","name":"Vasodilator Agents","relevance":"LOW"}],"browseBranches":[{"abbrev":"AnArAg","name":"Anti-Arrhythmia Agents"},{"abbrev":"ChanBlk","name":"Channel Blockers"},{"abbrev":"VaDiAg","name":"Vasodilator Agents"},{"abbrev":"All","name":"All Drugs and Chemicals"},{"abbrev":"BDCA","name":"Bone Density Conservation Agents"}]}},"hasResults":false}